Recent research has suggested that Ozempic, a medication primarily prescribed for managing Type 2 diabetes, may also play a significant role in reducing...
By 193cc Agency CouncilSeptember 26, 2024In a recent Senate testimony, Lars Jørgensen, the CEO of Novo Nordisk, defended the pricing of Ozempic, the company’s widely used medication for...
By 193cc Agency CouncilSeptember 24, 2024Recent research has illuminated the expanding potential of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, which were initially approved for diabetes management...
By 193cc Agency CouncilSeptember 5, 2024Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for weight loss and diabetes management, are now being investigated for their potential...
By 193cc Agency CouncilJuly 16, 2024A recent study published in JAMA Ophthalmology suggests that using Ozempic or Wegovy may elevate the risk of a rare form of blindness...
By 193cc Agency CouncilJuly 4, 2024A recent study published in the journal JAMA Network indicates that medications such as Ozempic and Wegovy, popular for weight loss, may lead...
By 193cc Agency CouncilJune 26, 2024In a comprehensive report analyzing trends in cosmetic surgery, 2023 saw a significant uptick in procedures such as fillers, Botox injections, facelifts, and...
By 193cc Agency CouncilJune 26, 2024Shares of Zealand Pharma soared by over 17% on Friday following the announcement of positive trial results for petrelintide, a potential competitor to...
By 193cc Agency CouncilJune 22, 2024The Federal Trade Commission (FTC) has raised concerns over the potential inflation of drug prices, specifically highlighting the impact on medications like Novo...
By 193cc Agency CouncilMay 1, 2024A comprehensive study recently conducted has shed new light on the potential correlation between GLP-1 medications like Ozempic and Wegovy and the risk...
By 193cc Agency CouncilApril 10, 2024